Imho that is the reason for so much uncertainty and it is clearly reflected in the share-price with the low and drifting volume.
Be great if the company could proactively give some update on this, they have been keeping it very tight to their chest. I understand the reasons. But being notified about it several months ago and nothing for so long is really annoying as a shareholder.
Communication has also been very light on for progress in UK with cross-selling opportunities. Is nearing 8 months now since the merge, would be great to get an update on progress, what hospitals think of MIYA, how many demo’s have seen the technology and what thoughts are.
